Replies to post #279582 on Avid Bioservices Inc (CDMO)

[biopharm]

Peregrine Pharmaceuticals Buy Low then Sell High

We are at the buy low stage and CEO Steve King doing a great job on the science side and the wall street side will catch up once a deal is announced and that could be any day now.

Memorial Sloan Kettering Dr. Jedd Wolchok just validated PS Targeting and still have AstraZeneca and Merck trials with PS Targeting

Biomarkers are all the hype and PS Targeting biomarkers are coming... actually in December just 2 weeks ago

Has anyone heard about the exosome test kits?

Avid manufacturing expansions?